When phase 3 trials are approved, it will hit the stratosphere as the first drug in the world that cures non-alcoholic fatty liver disease. Institutional funds will buy uppp
Traditional medicine and supplements are not drugs. The term clinical trials are applicable to drugs seeking FDA approval to market internationally esp. USA. Dont be fooled by all these claims. Just quote a scientific writeup. I wouldn't waste my money on this stock.
“This network helps us to treat and study the disease in an efficient manner. All these make up an additional value proposition which Malaysia can offer the world of science. This is another contributing factor why Malaysia is part of the CRC (Clinical Research Coalition),” he added.
Clinical trials and development of medicines and vaccines require strong protection of intellectual property (IP) rights. Malaysia, however, has a weak reputation for IP protection in the pharmaceutical sector and biological sciences.
Back in early March, the Pharmaceutical Research and Manufacturers of America (PhrMA) slammed Malaysia for poor protection of IP rights, and pushed the Trump administration to reverse compulsory licencing in Malaysia to end “discriminatory” market access practices.
The umbrella group made note of Malaysia’s “non-transparent” move to issue a compulsory licence for a breakthrough US-developed medicine that cures Hepatitis C, sofosbuvir.
Only biotech co with patented world's first hepar-p pursuing phase 3 clinical trials for NAFLD that till now has no cure. Blockbuster drug cumminggg
Why KPJ is next gem for post covid-19? Based on Fundamental analysis our current PE guideline is approx 57.14 (Based on 1.75% of BNM base rate) however KPJ PE=17.47@RM0.83 thus the actual price for KPJ should be RM2.71. Covid-19 only good for medical sector (more clearly is protective medical equipment “glove, mask, face shield and etc” and diagnosis instrument “thermo scanners, PCR tester and etc” For Malaysia top glove, harta, kossan and supermx all are the first round winners. For the last stage of vaccination development, now is the time to look for the next gem but unfortunately our country is impossible to produce these vaccine. The only vaccine we can get is import and we hv 20+mil ppl need to be vaccinated. Early stage of vaccine must be very expensive and gov won’t sponsor. We only can get vaccinated through private hospital no matter for travel or job requirement or just stay safe. Based on 2019, KPJ recorded 2,629,878 outpatients @ net profit 226.7mil with 28 hospitals overall the state. If half of 20mil ppl go KPJ for vaccination so approx net profit can reach up to 1bil. And u need to know tat those vaccine isn’t 1 injection for lifetime (like seasonally flu vaccine) and must get it semi or annually. RM1k-2k per vaccine per yrs for everyone to stay safe is new normal of post covid-19. And it is long term investment value of KPJ.
There are 23 potential vaccines developed and 3 candidates already passed the clinical trial and go for final stage of testing. 1. Moderna vaccine enter the final stage of human trials for its COVID-19 vaccine on July 27. 2. Oxford-AstraZeneca Covid-19 vaccine show good immune responses without side effect. 3. Chinese-made vaccine from Sinovac Biotech at final stage of testing in Brazil.
You are caught/trapped Only way out is to sell your shares cheap cheap. The price will go up after you and all who bought at high price follow u. This is called goreng
so you are buying on contra... depend on how much you will lose if cut loss... if a lot then you can buy it in and hold for long term... if not much and you dont want to waste time then just cut loss..I am holding la lol
For all newbies (1)90% of what you read here are rubbish.There is no sifu here. If they are so good he wont be hanging around here. (2)TP even from banks are pure guesswork.TP applies only next 6 to 12 months Not tomorrow or next week (3)Invest only in companies you know.
Hi hope888, I already sold Boustead earlier with small loss, as the proposed privatisation does not materialised & I do not have target price.The recent price spike was due to news of it's subsidiary Pharmaniaga involving in covid-19 vacine.Previously, this company was very profitable company with many listed subsidiaries, paying high dividend but it failed badly with poor GLC management, look like it still needs more time to turn around...Good luck !
The closest comparison to Nova Wellness is Blackmore's. Note closest, but actually really distant because their margins are vastly inferior add they do not have phase 3 trials for a disease that has no cure
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
shortinvestor77
5,487 posts
Posted by shortinvestor77 > 2020-07-22 12:57 | Report Abuse
Your shop, sj1993?